Evidence map›Paper›PMID 41474748›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Controlled dynamic remodeling of the spliceosome active site enables the first step of splicing.

Gianfranco Martino, Jacopo Manigrasso, Giuseppina La Sala, Marco Marcia, Marco De Vivo

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Controlled dynamic remodeling of the spliceosome active site enables the first step of splicing.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gianfranco MartinoLaboratory of Molecular Modelling and Drug Discovery, Istituto Italiano di Tecnologia, Genoa 16163, Italy.ORCID 0009-0009-2379-1611
Jacopo ManigrassoMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Mölndal 431 50, Sweden.ORCID 0000-0003-4076-8930
Giuseppina La SalaMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Mölndal 431 50, Sweden.ORCID 0000-0001-6565-197X
Marco MarciaEuropean Molecular Biology Laboratory Grenoble, Grenoble 38042, France.
Marco De VivoLaboratory of Molecular Modelling and Drug Discovery, Istituto Italiano di Tecnologia, Genoa 16163, Italy.ORCID 0000-0003-4022-5661

Funding

Fondazione AIRC per la ricerca sul cancro ETS (AIRC) 28746Fondazione AIRC per la ricerca sul cancro ETS (AIRC) 30631
6 · The paper itself

Abstract

Recent cryoelectron microscopy data have revealed significant conformational rearrangements of the megadalton spliceosome structure during splicing, an essential catalytic process for maturing most human transcripts. However, the molecular trigger of these structural rearrangements for splicing catalysis remains unclear at the atomic level. Here, by analyzing a consistent dataset of multicomponent spliceosome structures, we identified a minimal set of positively charged residues whose dynamic action remodels the spliceosome active site during the first step of splicing. Through equilibrium and enhanced sampling molecular dynamics simulations of multiple splicing intermediates (>2M atoms), we uncover how these residues dynamically operate in coordination with the transient, temporally ordered binding of key spliceosomal proteins (Prp11, Prp8, and Yju2) at the spliceosome core. Our findings reveal a molecular mechanism that ensures precise and timely spliceosome activation, opening promising directions to probe splicing regulation and potentially target its dysfunction in diseases, with broad implications for drug discovery and medicine.

Indexed as

RNA SplicingSpliceosomesCatalytic DomainCryoelectron MicroscopyHumansMolecular Dynamics SimulationNuclear ProteinsRNA Splicing FactorsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsNuclear ProteinsRNA Splicing FactorsSaccharomyces cerevisiae ProteinsYJU2 protein, S cerevisiaemolecular dynamicsRNA splicingsimulationsspliceosomesplicing factors

Identifiers

PMID41474748
PMCPMC12773743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.